stock.name

Finch Therapeutics Group Inc

FNCH

Market Cap$0
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Finch Therapeutics Group IncFinch Therapeutics Group Inc00%-327%-1.3

Share Statistics

Market cap$0.00
Enterprise Value$5.00 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-46.59
Beta0.0
Outstanding Shares1,605,763
Avg 30 Day Volume0

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-0.0
Price to Sales-
Price to Book Ratio0.09
Enterprise Value to Revenue46.75
Enterprise Value to EBIT-0.15
Enterprise Value to Net Income-1
Total Debt to Enterprise6.02
Debt to Equity1.32

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Finch Therapeutics Group Inc

131 employees

Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and ta...